| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/01/1997 | US5643574 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/01/1997 | US5643573 Drug delivery |
| 07/01/1997 | US5643569 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells |
| 07/01/1997 | US5643562 Method for treating amyloidosis |
| 07/01/1997 | US5643560 Drug formulation with ion-exchangers |
| 07/01/1997 | US5643555 Surfactant-free water-in-oil emulsion |
| 07/01/1997 | US5643553 Surfactant film forming saturated phospholipid in lamellar form |
| 07/01/1997 | US5643464 Process for preparing a sterile, dry crosslinking agent |
| 07/01/1997 | CA2027133C Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them |
| 06/30/1997 | CA2168680A1 Cytotoxic agents |
| 06/28/1997 | CA2193781A1 Contact lens containing a leachable absorbed material |
| 06/26/1997 | WO1997022879A1 Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system |
| 06/26/1997 | WO1997022630A1 Selective alkylations of cyclodextrins at the levels of minimal effective basicity |
| 06/26/1997 | WO1997022371A1 Crosslinked polymer compositions and methods for their use |
| 06/26/1997 | WO1997022368A2 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 06/26/1997 | WO1997022364A1 FCε-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 06/26/1997 | WO1997022363A2 Improved pharmaceutical compositions |
| 06/26/1997 | WO1997022358A1 Microemulsion preconcentrates comprising cyclosporins |
| 06/26/1997 | WO1997022356A1 Protected biopolymers for oral administration and methods of using same |
| 06/26/1997 | WO1997022347A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor. |
| 06/26/1997 | WO1997022345A1 Phospholipid and propylene glycol based lubricant |
| 06/26/1997 | WO1997022340A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 06/26/1997 | WO1997022337A1 Stabilised nanoparticles capable of being filtered under sterile conditions |
| 06/26/1997 | WO1997022336A1 Direct compression carbonyl iron tablet |
| 06/26/1997 | WO1997022335A1 A controlled release formulation for poorly soluble basic drugs |
| 06/26/1997 | WO1997019703A3 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 06/26/1997 | WO1997018816A3 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 06/26/1997 | WO1997010005A3 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 06/26/1997 | DE19549243A1 Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga A pharmaceutical composition comprising clathrates of cyclodextrins and non-natural vitamin D analogues |
| 06/26/1997 | DE19548114A1 Konjugat, umfassend einen Wirkstoff, ein Polypeptid und einen Polyether A conjugate comprising an active substance, a polypeptide and a polyether |
| 06/26/1997 | CA2244396A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 06/26/1997 | CA2241040A1 Improved pharmaceutical compositions |
| 06/26/1997 | CA2240640A1 Microemulsion preconcentrates comprising cyclosporins |
| 06/26/1997 | CA2240365A1 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 06/26/1997 | CA2239808A1 Direct compression carbonyl iron tablet |
| 06/26/1997 | CA2239787A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor |
| 06/25/1997 | EP0780129A2 Adrenal cortical steroid containing external therapeutic composition for dermatitis |
| 06/25/1997 | EP0780126A1 Ointment |
| 06/25/1997 | EP0780121A1 Eye lotion in particular for dry eye treatment |
| 06/25/1997 | EP0780114A1 Transparent nanoemulsion based on silicon tensio actives and its use in cosmetics or in dermopharmaceutics |
| 06/25/1997 | EP0779922A2 Modified human c3 proteins |
| 06/25/1997 | EP0779894A1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
| 06/25/1997 | EP0779818A1 Liquid immunoglobulin formulations |
| 06/25/1997 | EP0779814A1 Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications |
| 06/25/1997 | EP0779805A2 Sustained release of peptides from pharmaceutical compositions |
| 06/25/1997 | EP0707478A4 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | CN1152877A Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 06/25/1997 | CN1152876A Laerimal gland specific emulsions for topical application to ocular tissue |
| 06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
| 06/25/1997 | CN1152873A New pharmaceutical preparationf or pain management |
| 06/25/1997 | CN1152867A Methods and compositions for pulmonary delivery of insulin |
| 06/25/1997 | CN1152857A Cold water-dispersible compositions of fat-soluble active substances |
| 06/25/1997 | CN1152468A Slow releasing composition |
| 06/25/1997 | CN1152434A Oral preparation of S(+)1,8-diethyl-1,3,4,9-tetrahydropyrano (3,4-b) indole-1-acetic acid |
| 06/24/1997 | US5641865 Surfactant stabilized microheterogeneous dispersion of aqueous phase containing antibody or fragment thereof in water immiscible medium |
| 06/24/1997 | US5641760 Method of treating candida infection |
| 06/24/1997 | US5641757 Stable 2-chloro-2'-deoxyadenosine formulations |
| 06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641515 Complex of insulin and polyalkylcyanoacrylate or free-insulin loaded polyalkylcyanoacrylate |
| 06/24/1997 | US5641504 Transdermal drug delivery |
| 06/24/1997 | US5641483 Healing of cutaneous wounds, leg ulcers |
| 06/19/1997 | WO1997021744A1 Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 06/19/1997 | WO1997021452A2 Macromolecular prodrugs of nucleotide analogs |
| 06/19/1997 | WO1997021451A1 Anti-cocaine vaccine |
| 06/19/1997 | WO1997021448A1 A calcitonin preparation |
| 06/19/1997 | WO1997021444A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | WO1997021443A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | WO1997021440A1 A solution for oral administration containing ici 182,780 |
| 06/19/1997 | DE19547022A1 Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel Covalent lipid phosphonocarboxylic acid conjugates, their preparation and their use as antiviral drugs |
| 06/19/1997 | DE19546698A1 Copolymerisate aus Carbonsäuren und mehrfach olefinisch ungesättigten Carbonsäurederivaten und ihre Verwendung als Verdickungs- oder Dispergiermittel Copolymers of carboxylic acids and poly-olefin-unsaturated carboxylic acid derivatives and their use as thickeners or dispersants |
| 06/19/1997 | CA2239874A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | CA2239058A1 Anti-cocaine vaccine |
| 06/19/1997 | CA2237058A1 Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 06/18/1997 | EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses |
| 06/18/1997 | EP0778849A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/18/1997 | EP0778785A2 Methods and apparatus for the delivery of solid drug compositions |
| 06/18/1997 | EP0778780A1 Capsular polysaccharide immunomodulator |
| 06/18/1997 | EP0778778A1 Probiotic compositions |
| 06/18/1997 | EP0778775A1 Cosolvent parenteral formulation of tirilazad |
| 06/18/1997 | EP0778772A1 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 06/18/1997 | EP0778771A1 Topical ketoconazole emulsions |
| 06/18/1997 | EP0778768A1 Formulations and methods for providing prolonged local anesthesia |
| 06/18/1997 | EP0778767A2 Delivery of solid drug compositions |
| 06/18/1997 | EP0778731A1 Ionene polymers containing biologically-active anions |
| 06/18/1997 | EP0731812A4 POLY-beta-1-4-N-ACETYLGLUCOSAMINE |
| 06/18/1997 | EP0710110A4 Rapamycin conjugates and antibodies |
| 06/18/1997 | EP0521994B1 Pharmaceutical formulations |
| 06/18/1997 | EP0512064B1 Extracellular segments of human ige immunoglobulin anchoring peptides and antibodies specific therefor |
| 06/18/1997 | CN1151866A External therapeutic composition for dermatitis |
| 06/18/1997 | CN1151863A Mixed skin absorbent |
| 06/17/1997 | US5639797 Water-in-oil emulsions containing water-soluble alkyl glycosides |
| 06/17/1997 | US5639787 Administering ascorbic acid |
| 06/17/1997 | US5639738 Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| 06/17/1997 | US5639730 Heating in presence of a tenside |
| 06/17/1997 | US5639724 Carrier medium comprising a transesterification product of a natural vegetable oil and glycerol: mixture of mon-, di- and triglycerides |
| 06/17/1997 | US5639656 Antibodies reactive with biological markers of benign prostate hyperplasia |
| 06/17/1997 | US5639633 Stabilizing the protein by biochemical conjugation with linker groups |
| 06/17/1997 | US5639505 Applying a glassy carbohydrate film containing sugars and an allosteric effector on the substrate; reduced surface energy |